ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of SI-6603 in Patients With Lumbar Disc Herniation

ClinicalTrials.gov ID: NCT01941563

Public ClinicalTrials.gov record NCT01941563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 12:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01941563
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Seikagaku Corporation
Industry
Enrollment
385 participants

Conditions and interventions

Interventions

  • Condoliase Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2013
Primary completion
Oct 31, 2015
Completion
Jul 31, 2017
Last update posted
Mar 22, 2023

2013 – 2017

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
Not listed Phoenix Arizona
Not listed Gold River California
Not listed Laguna Hills California
Not listed Los Gatos California
Not listed Murrieta California
Not listed Riverside California
Not listed Denver Colorado
Not listed Hialeah Florida
Not listed Jacksonville Florida
Not listed Merritt Island Florida
Not listed Miami Florida
Not listed Naples Florida
Not listed North Miami Beach Florida
Not listed Orlando Florida
Not listed Pinellas Park Florida
Not listed Sarasota Florida
Not listed St. Petersburg Florida
Not listed Sunrise Florida
Not listed Winter Park Florida
Not listed Marietta Georgia
Not listed Newnan Georgia
Not listed Bloomington Illinois
Not listed Carmel Indiana
Not listed Shreveport Louisiana
Not listed City of Saint Peters Missouri
Not listed Hartsdale New York
Not listed Eugene Oregon
Not listed State College Pennsylvania
Not listed Charleston South Carolina
Not listed Dallas Texas
Not listed Sandy City Utah
Not listed Edmonds Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01941563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2023 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01941563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →